BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1708183)

  • 1. Recognition of a hepatitis B virus nucleocapsid T-cell epitope expressed as a fusion protein with the subunit B of Escherichia coli heat labile enterotoxin in attenuated salmonellae.
    Schödel F; Enders G; Jung MC; Will H
    Vaccine; 1990 Dec; 8(6):569-72. PubMed ID: 1708183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis in Vibrio cholerae and secretion of hepatitis B virus antigens fused to Escherichia coli heat-labile enterotoxin subunit B.
    Schödel F; Will H; Johansson S; Sanchez J; Holmgren J
    Gene; 1991 Mar; 99(2):255-9. PubMed ID: 2022336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hepatitis B virus antigens in attenuated Salmonellae for oral immunization.
    Schödel F; Will H
    Res Microbiol; 1990; 141(7-8):831-7. PubMed ID: 2101472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
    Bckström M; Holmgren J; Schödel F; Lebens M
    Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
    Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR
    J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine.
    Takahashi I; Kiyono H; Jackson RJ; Fujihashi K; Staats HF; Hamada S; Clements JD; Bost KL; McGhee JR
    Infect Immun; 1996 Apr; 64(4):1290-8. PubMed ID: 8606092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heat-labile Escherichia coli enterotoxin.
    Clements JD; Lyon FL; Lowe KL; Farrand AL; el-Morshidy S
    Infect Immun; 1986 Sep; 53(3):685-92. PubMed ID: 3527989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems.
    Maskell DJ; Sweeney KJ; O'Callaghan D; Hormaeche CE; Liew FY; Dougan G
    Microb Pathog; 1987 Mar; 2(3):211-21. PubMed ID: 3333799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins.
    Jagusztyn-Krynicka EK; Clark-Curtiss JE; Curtiss R
    Infect Immun; 1993 Mar; 61(3):1004-15. PubMed ID: 8432584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of mucosal protection against the heat-stable enterotoxin (ST) of Escherichia coli by oral immunization with a genetic fusion delivered by a bacterial vector.
    Cárdenas L; Clements JD
    Infect Immun; 1993 Nov; 61(11):4629-36. PubMed ID: 8406860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
    Byrd W; Boedeker EC
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous oral immunization of mice with live attenuated Escherichia coli expressing LT192-STa 13 and LT 192-STb fusion immunogen, respectively, for polyvalent vaccine candidate.
    Liu W; Li J; Bao J; Li X; Guan W; Yuan C; Tang J; Zhao Z; Shi D
    Appl Microbiol Biotechnol; 2015 May; 99(9):3981-92. PubMed ID: 25549617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a plasmid for expression of foreign epitopes as fusion proteins with subunit B of Escherichia coli heat-labile enterotoxin.
    Schödel F; Will H
    Infect Immun; 1989 Apr; 57(4):1347-50. PubMed ID: 2647637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a nontoxic fusion peptide for immunization against Escherichia coli strains that produce heat-labile and heat-stable enterotoxins.
    Clements JD
    Infect Immun; 1990 May; 58(5):1159-66. PubMed ID: 2182535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escherichia coli K88ac fimbriae expressing heat-labile and heat-stable (STa) toxin epitopes elicit antibodies that neutralize cholera toxin and STa toxin and inhibit adherence of K88ac fimbrial E. coli.
    Zhang C; Zhang W
    Clin Vaccine Immunol; 2010 Dec; 17(12):1859-67. PubMed ID: 20980482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope.
    Milich DR; Hughes JL; McLachlan A; Thornton GB; Moriarty A
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1610-4. PubMed ID: 2449694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae.
    Ryan ET; Crean TI; John M; Butterton JR; Clements JD; Calderwood SB
    Infect Immun; 1999 Apr; 67(4):1694-701. PubMed ID: 10085006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system.
    Dougan G; Hormaeche CE; Maskell DJ
    Parasite Immunol; 1987 Mar; 9(2):151-60. PubMed ID: 3106921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.